Compare
Embecta Corp. vs Haemonetics Corp vs Orthofix Medical Inc. vs Merit Medical Systems Inc
| Latest fiscal year | Embecta Corp. EMBC | Haemonetics Corp HAE | Orthofix Medical Inc. OFIX | Merit Medical Systems Inc MMSI |
|---|---|---|---|---|
| Year ended | 2025-09-30 | 2026-03-28 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.08B | $1.33B | $822.31M | $1.52B |
| Revenue growth (YoY) | -3.8% | -2.0% | +2.9% | +11.8% |
| Gross margin | 62.6% | 59.0% | 68.8% | 48.7% |
| Operating margin | 22.4% | 11.7% | -9.9% | 12.2% |
| Net margin | 8.8% | 7.3% | -11.2% | 8.5% |
| Net income | $95.40M | $97.31M | -$92.19M | $128.49M |
| EPS (Diluted) | $1.62 | $2.05 | -$2.33 | $2.13 |
| Operating cash flow | $191.70M | $293.22M | $33.35M | $297.37M |
| Free cash flow | $182.40M | $260.44M | -$1.28M | $215.66M |
| Cash & equivalents | $225.50M | $245.44M | $82.03M | $446.40M |
| Total assets | $1.09B | $2.40B | $850.65M | $2.69B |
| Total liabilities | n/a | n/a | $400.61M | $1.10B |
| Shareholders' equity | -$650.60M | $796.32M | $450.04M | $1.58B |
| Return on year-end equity | n/a | 12.2% | -20.5% | 8.1% |
| Shares outstanding | 58.50M | 45.25M | 39.83M | 59.42M |
Revenue, most recent five fiscal years
| Fiscal year | Embecta Corp. | Haemonetics Corp | Orthofix Medical Inc. | Merit Medical Systems Inc |
|---|---|---|---|---|
| Latest | $1.08B Ended 2025-09-30 | $1.33B Ended 2026-03-28 | $822.31M Ended 2025-12-31 | $1.52B Ended 2025-12-31 |
| 1 year earlier | $1.12B Ended 2024-09-30 | $1.36B Ended 2025-03-29 | $799.49M Ended 2024-12-31 | $1.36B Ended 2024-12-31 |
| 2 years earlier | $1.12B Ended 2023-09-30 | $1.31B Ended 2024-03-30 | $746.64M Ended 2023-12-31 | $1.26B Ended 2023-12-31 |
| 3 years earlier | $1.13B Ended 2022-09-30 | $1.17B Ended 2023-04-01 | $460.71M Ended 2022-12-31 | $1.15B Ended 2022-12-31 |
| 4 years earlier | $1.17B Ended 2021-09-30 | $993.20M Ended 2022-04-02 | $464.48M Ended 2021-12-31 | $1.07B Ended 2021-12-31 |